{
    "title": "111_hr5740",
    "content": "The text chunk discusses the notification, nondistribution, and recall of adulterated or misbranded drugs under the Federal Food, Drug, and Cosmetic Act. It outlines prohibited acts related to noncompliance with notification requirements and orders issued under specific sections of the Act. SEC. 568 outlines the notification, nondistribution, and recall of adulterated or misbranded drugs under the Federal Food, Drug, and Cosmetic Act. Any person required to register under section 510 must notify the Secretary of the identity and location of a drug if they believe it is adulterated or misbranded and poses a threat of serious adverse health consequences or death to humans or animals. The Secretary may request a voluntary recall of a drug believed to be adulterated, misbranded, or in violation of the Act, with notice to affected individuals. If there is reason to believe a drug may cause serious health consequences or death, an order may be issued to cease distribution and recall the drug. The Secretary has the authority to issue an order for a person to cease distribution of a drug if it may cause serious health consequences or death. The person must also provide notification to affected individuals. Any person subject to the order must immediately stop distribution and appeal within 24 hours if desired. The Secretary can issue an order for a person to stop distributing a drug if it poses serious health risks. The person must appeal within 24 hours, with an option for an informal hearing. The hearing must be held within 5 days, and a determination will be made after the hearing. The Secretary can issue an order to stop distributing a drug if it poses health risks. After an informal hearing, the Secretary will determine whether to amend the order for a drug recall, find inadequate grounds for the order, or confirm the order was appropriate. If an amendment is necessary, it will be made accordingly. The Secretary can issue an order to recall a drug if deemed necessary after an informal hearing. If an amendment for a recall is required, the order will be amended accordingly. The Secretary can issue a recall order for a drug, specifying a timetable, requiring progress reports, and providing notice to affected individuals. The order must be amended by the Secretary or a designated official. The Secretary may issue an emergency recall order for a drug if there is credible evidence of serious health risks. The order requires immediate recall of the drug and notification to affected individuals. Any person subject to an emergency recall order must immediately recall the drug and provide required notification. They can appeal the order within 24 hours to the Secretary, but the recall must continue during the appeal process. An informal hearing must be held promptly, within 5 days. After an emergency recall order, a person must recall the drug immediately and can appeal within 24 hours. An informal hearing must be held within 5 days to determine if the order should be amended or if it was appropriate as issued. After an emergency recall order, a person must recall the drug immediately and can appeal within 24 hours. An informal hearing must be held within 5 days to determine if the order should be amended or vacated. The order under this subsection shall be issued by specific officials of the Food and Drug Administration. The Secretary must provide notice to consumers and health officials. The Secretary must provide notice of a recall order to consumers and health officials. The amendments made by this section shall take effect one year after the enactment of this Act."
}